Skip to content

Randomized controlled trial on the improvement for the pregnancy outcome of recurrent implantation failure through preimplantation genetic testing for aneuploidy

Randomized controlled trial on the improvement for the pregnancy outcome of recurrent implantation failure through preimplantation genetic testing for aneuploidy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051025
Enrollment
Unknown
Registered
2021-09-10
Start date
2021-09-28
Completion date
Unknown
Last updated
2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Repeated implantation failure

Interventions

experimental group:Preimplantation genetic testing for aneuploidy
control group:histologic examination only

Sponsors

Chongqing Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 38 Years

Inclusion criteria

Inclusion criteria: 1. Meet the indications for IVF or ICSI; 2. The history of embryo transfer failures in the past >= 2 times, and the cumulative transfer of at least 4 transferable cleavage embryos or 2 transferable blastocysts; 3. Female age =1 blastocyst with morphological grade of 4BC/4CB and above on the 5th or 6th day (D5/6) after egg collection.

Exclusion criteria

Exclusion criteria: 1. People with low response to the number of oocytes retrieved 3cm; 4. Congenital uterine abnormalities (such as unicornuate uterus, septate uterus, or double uterus); 5. One or both spouses have abnormal karyotypes; 6. Repeated spontaneous abortion: 2 or more consecutive occurrences of fetal loss before 28 weeks of gestation, including consecutive biochemical pregnancy; 7. Untreated severe endocrine disease; 8. Severe male factor infertility: including severe oligospermia (sperm concentration < 5 x 10^6/ml), azoospermia, severe teratospermia (sperm deformity rate 100%), asthenozoospermia (forward motile sperm) rate 0%).

Design outcomes

Primary

MeasureTime frame
Live Birth Rate of the first embryo transfer;

Secondary

MeasureTime frame
Clinical Pregnancy Rate of the first embryo transfer;Continuous Pregnancy Rate;Miscarriage rate;Ectopic pregnancy rate;Cumulative Live Birth Rate during one cycle of egg retrieval;Time to live birth;

Countries

China

Contacts

Public ContactYe Hong

Chongqing Maternal and Child Health Hospital

yehong1210@163.com+86 23 63846879

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026